Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,574 | -4,603 | -10,538 | -7,366 | -5,037 |
| Depreciation Amortization | 12 | 6 | 306 | 300 | 298 |
| Accounts payable and accrued liabilities | -804 | -1,447 | 1,631 | -1,610 | 734 |
| Other Working Capital | -764 | -924 | -633 | -2,430 | 713 |
| Other Operating Activity | 2,550 | 2,602 | 2,029 | 4,847 | 2,152 |
| Operating Cash Flow | $-8,580 | $-4,366 | $-7,205 | $-6,259 | $-1,140 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,254 | 3,260 | -6,023 | -8,844 | N/A |
| Investing Cash Flow | $3,254 | $3,260 | $-6,023 | $-8,844 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 230 | 243 | 243 |
| Common Stock Issued | 11 | 8 | 20,242 | 20,242 | -279 |
| Financing Cash Flow | $11 | $8 | $20,472 | $20,485 | $-36 |
| Beginning Cash Position | 8,556 | 8,556 | 1,312 | 1,312 | 1,312 |
| End Cash Position | 3,241 | 7,458 | 8,556 | 6,694 | 136 |
| Net Cash Flow | $-5,315 | $-1,098 | $7,244 | $5,382 | $-1,176 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,580 | -4,366 | -7,205 | -6,259 | -1,140 |
| Free Cash Flow | -8,580 | -4,366 | -7,205 | -6,259 | -1,140 |